Zappe DH - Search Results

1

Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.

Brook RD, Kaciroti N, Bakris G, Dahlöf B, Pitt B, Velazquez E, Weber M, Zappe DH, Hau T, Jamerson KA. Brook RD, et al. Among authors: zappe dh. J Am Heart Assoc. 2018 Jan 4;7(1):e006940. doi: 10.1161/JAHA.117.006940. J Am Heart Assoc. 2018. PMID: 29301757 Free PMC article.

2

Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.

Kjeldsen SE, Jamerson KA, Bakris GL, Pitt B, Dahlöf B, Velazquez EJ, Hua TA, Kelly RY, Zappe D, Hester A, Tuomilehto J, Ostergren J, Ibsen H, Weber M; Avoiding Cardiovascular Events Through Combination Therapy In Patients Living With Systolic Hypertension (ACCOMPLISH). Kjeldsen SE, et al. Blood Press. 2012 Apr;21(2):82-7. doi: 10.3109/08037051.2011.598699. Epub 2011 Aug 10. Blood Press. 2012. PMID: 21830844 Clinical Trial.

3

Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.

Weber MA, Jamerson K, Bakris GL, Weir MR, Zappe D, Zhang Y, Dahlof B, Velazquez EJ, Pitt B. Weber MA, et al. Lancet. 2013 Feb 16;381(9866):537-45. doi: 10.1016/S0140-6736(12)61343-9. Epub 2012 Dec 6. Lancet. 2013. PMID: 23219284 Clinical Trial.

4

Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.

Weber MA, Bakris GL, Hester A, Weir MR, Hua TA, Zappe D, Dahlof B, Velazquez EJ, Pitt B, Jamerson K. Weber MA, et al. Am J Med. 2013 Jun;126(6):501-8. doi: 10.1016/j.amjmed.2013.01.007. Epub 2013 Mar 28. Am J Med. 2013. PMID: 23541376 Clinical Trial.

5

Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery disease.

Bakris G, Briasoulis A, Dahlof B, Jamerson K, Weber MA, Kelly RY, Hester A, Hua T, Zappe D, Pitt B; ACCOMPLISH Investigators. Bakris G, et al. Am J Cardiol. 2013 Jul 15;112(2):255-9. doi: 10.1016/j.amjcard.2013.03.026. Epub 2013 Apr 11. Am J Cardiol. 2013. PMID: 23582626 Clinical Trial.

6

Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy.

Weber MA, Bloch M, Bakris GL, Weir MR, Zappe DH, Dahlof B, Velazquez EJ, Pitt B, Basile JN, Jamerson K, Hua TA. Weber MA, et al. Among authors: zappe dh. J Clin Hypertens (Greenwich). 2016 Apr;18(4):299-307. doi: 10.1111/jch.12816. Epub 2016 Mar 28. J Clin Hypertens (Greenwich). 2016. PMID: 27060568 Free PMC article.

7

Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertension.

Zappe DH, Palmer BF, Calhoun DA, Purkayastha D, Samuel R, Jamerson KA. Zappe DH, et al. J Hum Hypertens. 2010 Jul;24(7):483-91. doi: 10.1038/jhh.2009.90. Epub 2009 Dec 10. J Hum Hypertens. 2010. PMID: 20010618 Free PMC article. Clinical Trial.

8

Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension.

Julius S, Palatini P, Kjeldsen SE, Zanchetti A, Weber MA, McInnes GT, Brunner HR, Mancia G, Schork MA, Hua TA, Holzhauer B, Zappe D, Majahalme S, Jamerson K, Koylan N. Julius S, et al. Am J Cardiol. 2012 Mar 1;109(5):685-92. doi: 10.1016/j.amjcard.2011.10.025. Epub 2011 Dec 9. Am J Cardiol. 2012. PMID: 22169130 Clinical Trial.

9

No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.

Kjeldsen SE, Berge E, Bangalore S, Messerli FH, Mancia G, Holzhauer B, Hua TA, Zappe D, Zanchetti A, Weber MA, Julius S. Kjeldsen SE, et al. Blood Press. 2016;25(2):83-92. doi: 10.3109/08037051.2015.1106750. Epub 2015 Oct 29. Blood Press. 2016. PMID: 26511535 Clinical Trial.

10

Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk.

Olsen E, Holzhauer B, Julius S, Kjeldsen SE, Larstorp ACK, Mancia G, Mehlum MH, Mo R, Rostrup M, Søraas CL, Zappe D, Weber MA. Olsen E, et al. Blood Press. 2021 Apr;30(2):90-97. doi: 10.1080/08037051.2020.1856642. Epub 2021 Jan 6. Blood Press. 2021. PMID: 33403890 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page